
Overview
Dr. Zhongbo Hu is a board-certified pediatrician with the Haley Center for Children’s Cancer and Blood Disorders at Orlando Health Arnold Palmer Hospital for Children. He provides care for children, teens and young adults, and his specialties include: Benign hematology disorders, such as Idiopathic thrombocytopenic purpura, leukopenia, anemia and hemophilia Oncology, including solid tumors Lymphomas, including hemophagocytic lymphohistiocytosis All different kinds of leukemias Dr. Hu’s philosophy is to treat patients and their families with empathy and respect. He strives to involve patients in decision-making and treatment planning as much as possible. Dr. Hu's Training Dr. Hu received his medical training at Beijing Medical University and Huazhong University of Science and Technology Tongji Medical College in China. He completed his residency in pediatrics at the University of Miami’s Jackson Memorial Medical Center / Holtz Children’s Hospital. Dr. Hu completed a pediatric hematology oncology fellowship with additional quality training at Case Western Reserve University Rainbow Babies & Children’s Hospital in Cleveland. About Dr. Hu Dr. Hu is board certified in pediatric hematology-oncology and general pediatrics by the American Board of Pediatrics. His professional memberships include the Children's Oncology Group, American Society of Pediatric Hematology Oncology, American Society of Hematology, American Association for Cancer Research and American Academy of Pediatrics. With his specific training in benign and malignant hematology research, Dr. Hu is passionate about developing new, targeted leukemia and anti-tumor therapies, including immune and cellular therapies. He has participated in several funded research projects during his post-doctoral training and his career as an assistant professor at the University of Florida. His main focus is clinical and translational research to improve treatments for pediatric leukemia, lymphoma, and other benign pediatric blood disorders and cancers. Dr. Hu also has received formal training through the Quality Training Program by the American Society of Clinical Oncology. He is actively involved in quality improvement projects to enhance patient care and enjoys teaching residents. Dr. Hu has held academic appointments, most recently as an assistant professor in the oncology department hospitalist medicine program at St. Jude Children’s Research Hospital and in the pediatrics department at the University of Tennessee Health Science Center, both in Memphis.
Dr. Hu is highly rated in 1 condition, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Acquired Amegakaryocytic Thrombocytopenia, Leukemia, and Sickle Cell Disease.
Dr. Hu is board certified in American Board Of Pediatrics - General Pediatrics and American Board Of Pediatrics - Pediatric Hematology And Oncology. He is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Graduate Institution
Residency
Specialties
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
92 W. Miller St., 2nd Floor, Orlando, FL 32806
Additional Areas of Focus
Dr. Hu has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Orlando Health Cancer Institute - Downtown Orlando
Jennifer Tseng, MD, hematologist/medical oncologist, is the Thoracic/Head and Neck Specialty Section leader for Medical Oncology and the associate director of Clinical Research for Medical Oncology at Orlando Health Cancer Institute.Dr. Tseng received her medical degree from Duke University School of Medicine. She completed her residency and served as assistant chief resident in internal medicine at Duke University Medical Center. She completed a fellowship in medical oncology and hematology at The University of Texas MD Anderson Cancer Center in Houston. She is board-certified in internal medicine and medical oncology and board-eligible in hematology. Dr. Tseng has received several honors and awards, including the C.D. Howe Award for clinical excellence in medical oncology and a Clinical Research Award from MD Anderson, the American Medical Women's Award, Hewlett Packard Award, the Alpha Omega Alpha Research Symposium Award from Duke University and a Beneficial-Hodgson scholarship from The Johns Hopkins University. She was also awarded Attending of the Year from the Internal Medicine Residency Program from Orlando Regional Medical Center and received the Exemplary Physician Colleague Award from Orlando Health in 2009.In addition to her clinical studies, Dr. Tseng has published research on various topics including molecular alterations in lung cancer and novel agents in the treatment of head and neck cancer. She has recently presented at the Annual Thoracic Oncology Symposium of the Puerto Rican Society of Hematology Oncology and spoke on neoadjuvant and adjuvant treatment strategies in lung cancer. Dr. Tseng is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Tseng is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Orlando Health Cancer Institute - Downtown Orlando
Dr. Tirrell Johnson is a board-certified medical oncologist at the Orlando Health Cancer Institute. His specialties include: Head and neck cancers Thoracic cancers Melanoma Sarcoma He is a member of the team pioneering a breakthrough protocol using tumor-infiltrating lymphocytes to address aggressive, late-stage melanoma. Dr. Johnson's Training Dr. Johnson earned a bachelor's degree in chemical engineering from Florida A&M University in Tallahassee, graduating magna cum laude, and received his medical degree from the University of Florida in Gainesville. He completed an internal medicine residency at Orlando Health Orlando Regional Medical Center and a fellowship in hematology and oncology at Brown University Medical School's teaching hospitals in Providence, Rhode Island. About Dr. Johnson Dr. Johnson is board certified in internal medicine and medical oncology by the American Board of Internal Medicine. His professional memberships include the American College of Physicians, American Society of Clinical Oncology and American Society of Hematology. Dr. Johnson received an Orlando Health award for outstanding multidisciplinary involvement with staff. He has served as the primary investigator for clinical trials studying several forms of chemotherapy for advanced head and neck cancers and thoracic malignancies. Dr. Johnson is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. Dr. Johnson is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Orlando Health Cancer Institute - Downtown Orlando
Omar Kayaleh, MD, serves as the medical oncology team leader for the Gastrointestinal Cancers Specialty Section and as a member of the Breast Cancer, Genitourinary Cancers, Hematology, Lymphoma/Myeloma and Thoracic/Head and Neck Cancers Specialty Sections at Orlando Health Cancer Institute. He also served as chairman of the Department of Internal Medicine as well as chief of the Hematology/ Oncology Specialty Section at Orlando Health Cancer Institute.Dr. Kayaleh received his medical degree from the University of Florida, completed a residency in internal medicine at Franklin Square Hospital in Baltimore and fulfilled a fellowship at the Medical University of South Carolina.Dr. Kayaleh is board-certified in internal medicine and in the specialties of medical oncology and hematology. He has held many offices and memberships on numerous medical staff committees, including Pharmacy and Therapeutics.He is a member of the Orange County Medical Society, Florida Medical Association, American Medical Association, American Society of Hematology, and the American Society of Clinical Oncology. Dr. Kayaleh is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Lynch Syndrome. Dr. Kayaleh is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine - Hematology.
Frequently Asked Questions about Dr. Zhongbo Hu
How do I make an appointment with Dr. Zhongbo Hu?
You can book an appointment with Dr. Zhongbo Hu by calling their office at 321-841-8588. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Zhongbo Hu a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Zhongbo Hu is classified as an Advanced expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Zhongbo Hu specialize in?
While Dr. Zhongbo Hu is a Hematology, they have specific expertise in Acute Lymphoblastic Leukemia (ALL), Acquired Amegakaryocytic Thrombocytopenia, and Leukemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Zhongbo Hu participate in research or clinical trials?
Yes. Dr. Zhongbo Hu has published 13 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Dr. Zhongbo Hu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Zhongbo Hu accept my insurance?
Dr. Zhongbo Hu accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 321-841-8588 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Experienced
- Acquired Amegakaryocytic Thrombocytopenia
- Febrile NeutropeniaDr. Hu isExperienced. Learn about Febrile Neutropenia.
- Infantile NeutropeniaDr. Hu isExperienced. Learn about Infantile Neutropenia.
- LeukemiaDr. Hu isExperienced. Learn about Leukemia.
- OsteosarcomaDr. Hu isExperienced. Learn about Osteosarcoma.
- Sickle Cell DiseaseDr. Hu isExperienced. Learn about Sickle Cell Disease.


